Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Transcriptome-wide study of TNF-inhibitor therapy in rheumatoid arthritis reveals early signature of successful treatment

Fig. 1

Heatmap of adalimumab good-responders and non-responders following real-time quantitative polymerase chain reaction (RT-qPCR) analysis of gene expression. Heatmap and hierarchal clustering is based on pairwise similarity in gene expression for the 104 transcripts measured in the RT-qPCR validation study. Good-responders and non-responders are represented in the upper and lower heatmaps, respectively. Heatmap rows and columns represent baseline and 3 months samples for 11 rheumatoid arthritis patients on adalimumab TNF-inhibitor therapy. BL = baseline and 3M = 3-months

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us